* |
If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** |
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) |
Shares acquired pursuant to the merger (the "Merger") in which a wholly owned subsidiary of Symantec Corporation ("Symantec") was merged with and into Blue Coat, Inc. ("Blue Coat"). The Reporting Person held 59,219.77 restricted stock units to acquire Blue Coat common stock that were exchanged for restricted stock units to acquire Symantec common stock in the Merger. On the effective date of the Merger, the closing price of Symantec's common stock was $20.55 per share. Shares to vest 30% on August 1, 2017, 30% on August 1, 2018, and 40% on August 1, 2019. |
(2) |
Shares acquired pursuant to the Merger. The Reporting Person held 73,202.22 restricted stock units to acquire Blue Coat common stock that were exchanged for restricted stock units to acquire Symantec common stock in the Merger. On the effective date of the Merger, the closing price of Symantec's common stock was $20.55 per share. Shares to vest in equal quarterly installments from August 1, 2016 over a period of approximately two years, ending June 1, 2018. |
(3) |
370,445 options are fully vested as of August 1, 2016. The remaining options vest and become exercisable in equal monthly installments over a period of two years, beginning August 1, 2016. |
(4) |
Acquired pursuant to the Merger. The Reporting Person held an employee stock option to acquire 997,000 shares of Blue Coat common stock for $12.40 per share that was exchanged for this option to purchase shares of common stock of Symantec in the Merger. |